Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Apothekergaarden Ejendomme ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1%   Bankruptcy risk   2.1% 2.3% 1.8% 1.9% 1.7% 1.7% 10.1% 9.9%   Credit score (0-100)   69 66 72 69 72 71 24 25   Credit rating   A BBB A A A A BB BB   Credit limit (kDKK)   0.6 0.1 8.0 1.2 8.9 3.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,885 3,116 2,848 2,574 2,937 2,679 0.0 0.0   EBITDA   9,366 -46.5 2,848 2,574 2,937 2,679 0.0 0.0   EBIT   5,625 1,535 8,572 2,796 4,160 4,429 0.0 0.0   Pre-tax profit (PTP)   4,105.4 363.3 7,534.8 1,738.9 8,222.1 2,249.0 0.0 0.0   Net earnings   3,181.2 275.2 5,890.0 1,365.0 6,487.5 1,787.2 0.0 0.0   Pre-tax profit without non-rec. items   4,105 363 7,535 1,739 8,222 2,249 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   34,995 54,300 56,790 55,327 56,550 58,300 0.0 0.0   Shareholders equity total   3,534 3,809 9,699 1,964 7,201 2,988 1,163 1,163   Interest-bearing liabilities   36,519 50,973 46,620 52,279 45,467 50,010 0.0 0.0   Balance sheet total (assets)   41,087 56,690 59,109 57,668 57,701 58,300 1,163 1,163   Net Debt   32,436 50,973 46,620 52,278 44,324 50,010 -1,163 -1,163     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,885 3,116 2,848 2,574 2,937 2,679 0.0 0.0   Gross profit growth   135.6% 65.4% -8.6% -9.6% 14.1% -8.8% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   41,087 56,690 59,109 57,668 57,701 58,300 1,163 1,163   Balance sheet change%   16.1% 38.0% 4.3% -2.4% 0.1% 1.0% -98.0% 0.0%   Added value   5,625.5 1,534.8 8,571.8 2,795.7 4,160.2 4,429.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   6,707 19,305 2,490 -1,463 1,223 1,750 -58,300 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   298.5% 49.3% 300.9% 108.6% 141.7% 165.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   14.8% 3.2% 14.9% 4.9% 18.9% 7.6% 0.0% 0.0%   ROI %   15.2% 3.3% 15.3% 5.0% 19.7% 8.1% 0.0% 0.0%   ROE %   112.0% 7.5% 87.2% 23.4% 141.6% 35.1% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   8.6% 6.7% 16.4% 3.4% 12.5% 5.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   346.3% -109,623.4% 1,636.7% 2,031.0% 1,509.3% 1,866.5% 0.0% 0.0%   Gearing %   1,033.4% 1,338.2% 480.7% 2,662.3% 631.4% 1,673.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.5% 2.8% 2.2% 2.3% 5.5% 4.6% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.5 0.2 0.2 0.1 0.1 0.0 0.0 0.0   Current Ratio   0.5 0.2 0.2 0.1 0.1 0.0 0.0 0.0   Cash and cash equivalent   4,083.5 0.2 0.2 0.2 1,142.7 0.2 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -6,707.6 -8,849.6 -7,003.3 -14,367.8 -12,074.0 -19,342.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0